• Mashup Score: 0

    A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health, has begun enrolling volunteers at Duke University in Durham, North Carolina. This Phase 1 trial will test the experimental vaccine, known as H1ssF-3928 mRNA-LNP, for…

    Tweet Tweets with this article
    • #ClinicalTrial of mRNA Universal #Influenza Vaccine Candidate Begins | NIH: National Institute of Allergy and Infectious Diseases https://t.co/ylwFgLwfyo "This #Phase1 trial will test the experimental #universalvaccine, known as #H1ssF3928 #mRNALNP [Lipid #NanoParticle], for… https://t.co/8nypTRbrGU

  • Mashup Score: 0

    New findings from the McGuire Lab report a promising approach towards vaccine design for Epstein-Barr Virus.

    Tweet Tweets with this article
    • A (literally) multi-pronged viral #vaccine approach https://t.co/kpEK4DRrUp via @fredhutch Immunization with a self-assembling #nanoparticle vaccine displaying #EBV gH/gL protects humanized mice against lethal viral challenge https://t.co/eHXmDgBA0w #EpsteinBar #mono #MS https://t.co/gva5zcuap9